跳至主要内容
临床试验/CTRI/2019/11/021957
CTRI/2019/11/021957尚未招募不适用

ASSESSMENT OF HORMONE RECEPTOR EXPRESSIONHETEROGENEITY IN CARCINOMA BREAST:AN IMMUNOHISTOCHEMICALSTUDY

PRIYANKA YADAV1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年11月30日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
IMMUNOHISTOCHEMICAL VARIATION IN ER PR HER2NEU

研究概览

简要总结

THIS STUDY IS AN OBSERVATIONAL IMMUNIHISTOCHEMICAL STUDY WHICH AIMS AT STUDYING THE VARIANCE IN ER PR HER2NEU EXPRESSION IN SAMPLE OBTAINED VIA TRUCUT BIOPSY AND THEIR COMPLETE EXCISION SPECIMEN AND ALSO THE VARIANCE OCCURING DUE TO CHEMOTHERAPY.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
Female

入选标准

  • •1 Newly diagnosed cases of breast carcinoma.
  • •2 Age more than 18 year.
  • •3 Willing to get treated in the same hospital.

排除标准

  • •1 Previous endocrine or chemotherapy 2 Patients undergone lumpectomy as diagnostic procedure.

结局指标

主要结局

IMMUNOHISTOCHEMICAL VARIATION IN ER PR HER2NEU

时间窗: 6 MONTHS

次要结局

  • ASSOCIATION OF HORMONE RECEPTOR EXPRESSION WITH REPONSE TO CHEMOTERAPY(6 MONTHS)

研究者

发起方
PRIYANKA YADAV
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验